HAVN Life Sciences (XCNQ:HAVN) FCF Margin % : -2,408.33% (As of Jan. 2023)

View and export this data going back to 2020. Start your Free Trial

What is HAVN Life Sciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. HAVN Life Sciences's Free Cash Flow for the three months ended in Jan. 2023 was C$0.29 Mil. HAVN Life Sciences's Revenue for the three months ended in Jan. 2023 was C$-0.01 Mil. Therefore, HAVN Life Sciences's FCF Margin % for the quarter that ended in Jan. 2023 was -2,408.33%.

As of today, HAVN Life Sciences's current FCF Yield % is 0.00%.

The historical rank and industry rank for HAVN Life Sciences's FCF Margin % or its related term are showing as below:

XCNQ:HAVN' s FCF Margin % Range Over the Past 10 Years
Min: -444.63 Med: 0 Max: 0
Current: -444.63

XCNQ:HAVN's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -143.92 vs XCNQ:HAVN: -444.63

HAVN Life Sciences FCF Margin % Historical Data

The historical data trend for HAVN Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAVN Life Sciences FCF Margin % Chart

HAVN Life Sciences Annual Data

Trend

Apr20

Apr21

Apr22

FCF Margin %

-2,890.58

HAVN Life Sciences Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23
FCF Margin %	Get a 7-Day Free Trial							-6,360.87	-671.30	-1,310.29	-177.14	-2,408.33

Competitive Comparison of HAVN Life Sciences's FCF Margin %

For the Biotechnology subindustry, HAVN Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HAVN Life Sciences's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HAVN Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where HAVN Life Sciences's FCF Margin % falls into.

HAVN Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

HAVN Life Sciences's FCF Margin for the fiscal year that ended in Apr. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Apr. 2022 )	/	Revenue (A: Apr. 2022 )
	=	-7.978	/	0.276
	=	-2,890.58 %

HAVN Life Sciences's FCF Margin for the quarter that ended in Jan. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jan. 2023 )	/	Revenue (Q: Jan. 2023 )
	=	0.289	/	-0.012
	=	-2,408.33 %

HAVN Life Sciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of HAVN Life Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

HAVN Life Sciences (XCNQ:HAVN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HAVN Life Sciences Inc (XCNQ:HAVN) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

HAVLF:USA

Address

605 - 130 Brew Street, Port Moody, BC, CAN, V3H 0E3

Website

https://www.havnlife.com

HAVN Life Sciences Inc is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, it offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.

HAVN Life Sciences (XCNQ:HAVN) Headlines

No Headlines